corrections to fluvoxamine evaluation report static content

Open-Systems-Pharmacology / Fluvoxamine-Model

Whole-body PBPK model of fluvoxamine as CYP1A2 and CYP3A4 DDI perpetrator drug

0 stars 3 forks source link

Closed TWendl closed 4 years ago

TWendl commented 4 years ago

• Please kindly add link to sections on page 11 (3.2 Diagnostics Plots) and 13 (3.3 Concentration-Time Profiles)